Correlation Between Structure Therapeutics and Spruce Biosciences

Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Spruce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Spruce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Structure Therapeutics American and Spruce Biosciences, you can compare the effects of market volatilities on Structure Therapeutics and Spruce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Spruce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Spruce Biosciences.

Diversification Opportunities for Structure Therapeutics and Spruce Biosciences

0.84

Correlation Coefficient

Structure Therapeutics  Spruce Biosciences

Very poor diversification

The 3 months correlation between Structure and Spruce is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Spruce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spruce Biosciences and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Spruce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spruce Biosciences has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Spruce Biosciences go up and down completely randomly.

Pair Corralation between Structure Therapeutics and Spruce Biosciences

If you would invest  7.19  in Spruce Biosciences on May 9, 2025 and sell it today you would earn a total of  0.00  from holding Spruce Biosciences or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	1.64%
Values	Daily Returns

Structure Therapeutics America  vs.  Spruce Biosciences

Structure Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Structure Therapeutics American has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in September 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Spruce Biosciences

Risk-Adjusted Performance

Weakest

Over the last 90 days Spruce Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Spruce Biosciences is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Structure Therapeutics and Spruce Biosciences

The main advantage of trading using opposite Structure Therapeutics and Spruce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Spruce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spruce Biosciences will offset losses from the drop in Spruce Biosciences' long position.

The idea behind Structure Therapeutics American and Spruce Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.